Larvol Delta - Effectiveness-of-the-Approved-NirmatrelvirRitonavir-and-Molnupiravir-Regimens-for-Treatment-of-MildModerate-LaboratoryConfirmed-SARSCoV2-Infection-in-Patients-Aged-1864-Years-in-Hong-Kong-A-PopulationBased-Cohort-Study

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

Lagevrio (molnupiravir) - Ridgeback Biotherap, Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42397514

Benjamin J Cowling; George N Okoli; Peng Wu; Yun Lin

Jul 4, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next